Patent · US Active

4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication

US11351186B2 · kind B2 · utility

0Cited by

15References

14Claims

0Family size

Assignee

Riboscience LLC · US

Inventors

Mark Smith · Saffron Walden, GB
Klaus G. Klumpp · West Chester, US

Key dates

Filing date	May 4, 2020
Grant date	Jun 7, 2022
Priority date	—
Expiry date	May 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Cytidine nucleoside analogues of Formula I, wherein the variables are as described herein, in combination with uridine nucleoside analogues of Formula II, wherein the variables are as described herein, produce a synergistic effect on the inhibition of HCV polymerase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.